Paulus A F Geerts

6PUBLICATIONS
19CO-AUTHORS
AutoimmunityPredictive and prognostic markersGene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 16, 2026
Zanubrutinib in AL Amyloidosis Associated With Waldenström Macroglobulinemia and Other B-Cell Non-Hodgkin Lymphoma.

Wouter Verhaar, Flores Weverling, Jahanzaib Khwaja

|Jun 01, 2023
Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion.

Paulus A F Geerts, Nils 't Hart, Otto Visser

|May 20, 2023
Rationale and development of an e-health application to deliver patient-centered care during treatment for recently diagnosed multiple myeloma patients: pilot study of the MM E-coach.

Paul Geerts, Job Eijsink, Albine Moser

|Mar 16, 2022
Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.

Mirian Brink, Monique C Minnema, Otto Visser

|May 04, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek

|Jul 13, 2019
Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs.

Paul A F Geerts, Trudy van der Weijden, Pien G M Loeffen

Pageof 1

Frequent Collaborators

2 joint publications

Pieter Sonneveld

2 joint publications

Mark-David Levin

2 joint publications

Monique C Minnema

1 joint publications

Claudia A M Stege